Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Bento-Abreu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|April 29, 2021
Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in BelgiumSteven Simoens, Andre Bento-Abreu, Barbara Merckx, et al.
Brain : a Journal of Neurology|February 5, 2013
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosisThomas Philips, Andre Bento-Abreu, Annelies Nonneman, et al.
Human Molecular Genetics|July 6, 2016
Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A miceKim A Staats, Stephanie Humblet-Baron, Andre Bento-Abreu, et al.
Acta Neuropathologica|January 6, 2018
A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanismBart Swinnen, Andre Bento-Abreu, Tania F Gendron, et al.
Human Molecular Genetics|February 8, 2018
Elongator subunit 3 (ELP3) modifies ALS through tRNA modificationAndre Bento-Abreu, Gunilla Jager, Bart Swinnen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|April 29, 2021
Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in BelgiumSteven Simoens, Andre Bento-Abreu, Barbara Merckx, et al.
Brain : a Journal of Neurology|February 5, 2013
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosisThomas Philips, Andre Bento-Abreu, Annelies Nonneman, et al.
Human Molecular Genetics|July 6, 2016
Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A miceKim A Staats, Stephanie Humblet-Baron, Andre Bento-Abreu, et al.
Acta Neuropathologica|January 6, 2018
A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanismBart Swinnen, Andre Bento-Abreu, Tania F Gendron, et al.
Human Molecular Genetics|February 8, 2018
Elongator subunit 3 (ELP3) modifies ALS through tRNA modificationAndre Bento-Abreu, Gunilla Jager, Bart Swinnen, et al.
Pageof 1